Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?

@article{Nelson2014SubcutaneousIV,
  title={Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?},
  author={H. Stanley Nelson},
  journal={The journal of allergy and clinical immunology. In practice},
  year={2014},
  volume={2 2},
  pages={144-9; quiz 150-1}
}
Subcutaneous immunotherapy (SCIT) and sublingual immunotherapy (SLIT) are both effective treatments for allergic rhinitis and allergic asthma, both show clinical evidence of disease modification by decreasing new sensitizations in individuals who were monosensitized, by reducing the development of asthma in patients with allergic rhinitis, and by inducing clinical improvement that persists for years after discontinuation of a successful course of treatment. Initiation of SLIT is accompanied by… CONTINUE READING